
Strategic Evaluation Framework (SEF) for MPTs: Strategic Target Profile (STP) context summaries
Building upon the IMPT’s report: “Laying the Groundwork for a Strategic Evaluation Framework (SEF) for HIV Prevention and MPT Product Development,” the IMPT initiated the next steps to create a Strategic Target Profile (STP) for the dominant MPT product strategies in development: daily oral tablets; on-demand, intermediate acting (e.g., gel, film, vaginal insert, barrier method); long-acting topical (e.g., patch, intravaginal ring [IVR]); and ultra-long-acting systemic (e.g., implant, injectable, intrauterine device [IUD]). This exercise aimed to synthesize learnings from end-user research in HIV prevention, family planning, and MPT development to inform target-setting around the ten identified STP attributes.
Click here to View Report
October 2017
Click for full info +Strategic Evaluation Framework (SEF) for MPTs: Strategic Target Profile (STP) context summaries
![]() | October 2017 Building upon the IMPT’s report: “Laying the Groundwork for a Strategic Evaluation Framework (SEF) for HIV Prevention and MPT Product Development,” the IMPT initiated the next steps to create a Strategic Target Profile (STP) for the dominant MPT product strategies in development: daily oral tablets; on-demand, intermediate acting (e.g., gel, film, vaginal insert, barrier method); long-acting topical (e.g., patch, intravaginal ring [IVR]); and ultra-long-acting systemic (e.g., implant, injectable, intrauterine device [IUD]). This exercise aimed to synthesize learnings from end-user research in HIV prevention, family planning, and MPT development to inform target-setting around the ten identified STP attributes. Click here to View Report |
Full Info:
Resource Type:
Citation:
Building upon the IMPT’s report: “Laying the Groundwork for a Strategic Evaluation Framework (SEF) for HIV Prevention and MPT Product Development,” the IMPT initiated the next steps to create a Strategic Target Profile (STP) for the dominant MPT product strategies in development…
Health Risks(s):
- HIV
- Unintended Pregnancy
Product type(s):
- AVRs
- CervicalBarrier
- Contraceptives
- Implants
- IUD
- IVR
- MPTs
- VaginalCream
- VaginalFilm
- Other
Topic(s):
- Education
- MPTs
- Development
- Product Introduction
Region(s)
- Global